教員紹介

SDGsへの取り組み

最終学歴

東京大学大学院　医学系研究科　医学博士課程修了

取得学位

博士（医学）　東京大学大学院

現在の専門分野

腫瘍学、生化学

現在の研究課題

●肝胆膵領域臓器がんに対する新規化学療法の構築に関する研究
●難治性がん疾患の高感度診断に有効な新規マテリアルおよび技術の開発に関する研究

主要研究業績

●肝胆膵領域臓器がんに対する新規化学療法の構築に関する研究
●難治性がん疾患の高感度診断に有効な新規マテリアルおよび技術の開発に関する研究

最近の研究業績

Biomed Pharmacother. 99, 921-930, 2018.
11. Shirata C, Kaneko J, Inagaki Y, Kokudo T, Sato M, Kiritani S, Akamatsu N, Arita J, Sakamoto Y, Hasegawa K, Kokudo N. Near-infrared photothermal/photodynamic therapy with indocyanine green induces apoptosis of hepatocellular carcinoma cells through oxidative stress. Sci Rep. 7(1), 13958, 2017.
12. Xia J, Inagaki Y, Gao J, Qi F, Song P, Han G, Sawakami T, Gao B, Luo C, Kokudo N, Hasegawa K, Sakamoto Y, Tang W. Combination of Cinobufacini and Doxorubicin Increases Apoptosis of Hepatocellular Carcinoma Cells through the Fas- and Mitochondria-Mediated Pathways. Am J Chin Med. 45(7), 1537-1556, 2017.
13. Inagaki Y, Matsumoto Y, Tang W, Sekimizu K. Dividing phase-dependent cytotoxicity profiling of human embryonic lung fibroblast identifies candidate anticancer reagents. Drug Discov Ther. 10(4), 195-200, 2016.
14. Xia J, Inagaki Y, Sawakami T, Song P, Cai Y, Hasegawa K, Sakamoto Y, Akimitsu N, Tang W, Kokudo N. Preliminary investigation of five novel long non-coding RNAs in hepatocellular carcinoma cell lines. Biosci Trends. 10(4), 315-9, 2016.
15. Inagaki Y, Matsumoto Y, Ishii M, Uchino K, Sezutsu H, Sekimizu K. Fluorescence imaging for a noninvasive in vivo toxicity-test using a transgenic silkworm expressing green fluorescent protein. Sci Rep. 5, 11180, 2015.
16. Adachi T, Matsumoto Y, Inagaki Y, Sekimizu K. Niemann-Pick disease type C2 protein induces autophagy and inhibits growth in FM3A breast cancer cells. Drug Discov Ther. 9(4), 282-8, 2015.
17. Song P, Inagaki Y, Wang Z, Hasegawa K, Sakamoto Y, Arita J, Tang W, Kokudo N. High Levels of Gamma-Glutamyl Transferase and Indocyanine Green Retention Rate at 15 min as Preoperative Predictors of Tumor Recurrence in Patients With Hepatocellular Carcinoma. Medicine (Baltimore). 94(21), e810, 2015.

受賞

総説
1. Kaneko J, Kokudo T, Inagaki Y, Hasegawa K. Innovative treatment for hepatocellular carcinoma (HCC). Transl Gastroenterol Hepatol. 3, 78, 2018.
2. Xia J, Inagaki Y, Song P, Sawakami T, Kokudo N, Hasegawa K, Sakamoto Y, Tang W. Advance in studies on traditional Chinese medicines to treat infection with the hepatitis B virus and hepatitis C virus. Biosci Trends. 10(5), 327-336, 2016.
3. Song PP, Xia JF, Inagaki Y, Hasegawa K, Sakamoto Y, Kokudo N, Tang W. Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma. World J Gastroenterol. 22(1), 262-74, 2016.
4. Gao JJ, Shi ZY, Xia JF, Inagaki Y, Tang W. Sorafenib-based combined molecule targeting in treatment of hepatocellular carcinoma. World J Gastroenterol. 21(42), 12059-70, 2015.
5. Inagaki Y, Song P, Tang W, Kokudo N. Cancer-associated carbohydrate antigens for clinical diagnostic markers - its effectiveness and limitations. Drug Discov Ther. 9(2), 129-32, 2015.